China Monoclonal Antibody (mAbs) Markets Report 2022-2026 & 2031 Featuring Shanghai Roche Pharmacy & Wuhan Institute of Biological Products – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Monoclonal Antibody Markets in China” report has been added to ResearchAndMarkets.com’s offering.

China’s demand for Monoclonal Antibody has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow.

The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades.

This new study examines China’s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2011, 2016 and 2021) and long-term forecasts through 2026 and 2031 are presented.

Major producers in China are also profiled.

Key Topics Covered:

I. INTRODUCTION

• Report Scope and Methodology
• Executive Summary

II. BUSINESS ENVIRONMENT

• Economic Outlook
• Key Economic Indicators
• Industrial Output
• Population
• Foreign Investment
• Foreign Trade
• Financial and Tax Regulations
• Banking System and Regulations
• Foreign Exchange
• Taxes, Tariff and Custom Duties

III. MONOCLONAL ANTIBODY INDUSTRY ASSESSMENTS

• Monoclonal Antibody Industry Structure
• Market Size
• Market Growth Drivers
• Monoclonal Antibody Sales Volume
• Major Producer Facility Locations and Sales Volume
• Market Share of Key Producers
• Labor Cost
• Potential Entrants
• Major Distributors
• Major Foreign Investments
• Technology Development

IV. MONOCLONAL ANTIBODY PRODUCTION AND DEMAND

• Overview
• Demand of Monoclonal Antibody by Region
• Monoclonal Antibody Sales Volume
• Cancer Treatment Antibody
• Autoimmunity Diseases Treatment Antibody
• Infection Treatment Antibody
• Cardiovascular Diseases Treatment Antibody
• Rejection of Organ Transplantation Treatment Antibody
• Other Diseases Treatment Antibody
• Monoclonal Antibody Imports
• Monoclonal Antibody Imports
• Cancer Treatment Antibody Import
• Autoimmunity Diseases Treatment Antibody Import
• Infection Treatment Antibody Import
• Cardiovascular Diseases Treatment Antibody Import
• Rejection of Organ Transplantation Treatment Antibody Import
• Other Diseases Treatment Antibody Import
• Pricing Trend

V. MONOCLONAL ANTIBODY MARKET OUTLOOK

• Monoclonal Antibody Markets Outlook Overview
• Government Regulations
• Health Care Insurance Industry Overview
• Consumer Spending Trends
• Northeast
• North
• Southeast
• Central
• Southwest
• Northwest
• Demographic Trends
• Health Care Industry Trends
• Hospitals and Hospital Beds

VI. MARKETING STRATEGIES

• China Market Entry Overview
• China’s Distribution System
• Distribution Channels
• Transportation and Freight Infrastructure
• Communications
• China’s Market Entry
• Licensing
• Franchising
• E-commerce
• Trading Companies and Local Agents
• Representative Offices and Chinese Subsidiaries
• Wholly Foreign Owned Enterprises

VII. MONOCLONAL ANTIBODY PRODUCER DIRECTORY

Companies Mentioned

• Shanghai Roche Pharmacy Co., Ltd.
• Wuhan Institute of Biological Products (WIBP)

For more information about this report visit https://www.researchandmarkets.com/r/6pke8u

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./ CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900